Obesity and Metabolic Syndrome Seems to be Risk Factors for Severe Influenza, COVID-19

Severe influenza and COVID-19 severity are increased in patients due to obesity and metabolic syndrome, reports a new study.

Metabolic syndrome raises the risk of severe disease from a viral infection, reveals a new study. The findings of the study are published in the Journal of Virology.

Metabolic syndrome conditions include excess abdominal fat, high blood pressure, excess blood sugar, abnormalities of lipids (including excess triglycerides and cholesterol), insulin resistance and a proinflammatory state.

Coffee Consumption Lowers Risk of Metabolic Syndrome
Drinking coffee moderately can reduce the risk of metabolic syndrome (MetS), a co-occurrence of several cardiovascular risk factors including obesity, hypertension and diabetes.

‘Metabolic syndrome is a cluster of at least three co-occurring conditions that raise heart disease risk, stroke and type 2 diabetes mellitus (T2DM). ’
Read More..

Multiple studies have shown that obesity is associated with increased severity of influenza A, higher viral titers in exhaled breath, and prolonged transmission of the virus, according to the report. According to the report, changes in the viral population may abet the emergence of more pathogenic influenza variants. Despite the fact that influenza vaccines generate robust antibody titers in obese subjects, obesity doubles the likelihood of developing influenza.

As with the influenza virus, the Centers for Disease Control and Prevention recently recognized obesity as a risk factor for severe illness caused by SARS-CoV-2. "This is not surprising because excess body weight and fat deposition apply pressure to the diaphragm, which further increases the difficulty of breathing during a viral infection," the researchers write.

But the risk goes beyond the burden of excess weight. A recent study highlighted in the literature review looked at 174 diabetes patients with confirmed cases of COVID-19. The study found that these patients were at significantly higher risk for severe pneumonia compared to non-diabetic COVID-19 patients. CT scans revealed a greater severity of lung abnormalities in these patients.

Metabolic Syndrome: Reversing the Syndrome can Cut Down Heart Disease Risk
Metabolic syndrome (hypertension, diabetes, excess abdominal fat, high triglyceride level, unhealthy cholesterol levels) can put you at an increased risk of cardiovascular disease. However, recovering from metabolic syndrome can reduce the risk of heart disease.

There was also a profound increase in serum IL-6 levels, a predictive biomarker for disease severity, the investigators write. These data imply that SARS-CoV-2 causes severe disease in obese patients and in those with T2DM by inducing bilateral pneumonia and a cytokine storm that damages the lung epithelial-endothelial barrier. (The epithelium lines surfaces exposed to the outer environment, such as the respiratory tract, the endothelium lines inner pathways such as those of the vasculature.)

However, one hypothetical risk for patients with T2DM who have hypertension or heart disease appears not to be a problem, after all, according to the report. These patients are commonly treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). These increase expression of ACE2, the receptor that SARS-CoV-2 uses to gain entry into cells.

Greener Environment Might Reduce the Risk of Metabolic Syndrome
Adults who live in greener neighborhoods have a lower chance of developing metabolic syndrome than those living in areas with less exposure to greenery.

Clinicians and researchers were initially concerned that ACE inhibitors and ARBs could promote adhesion and entry of SARS-CoV-2 into host cells, thereby increasing the risk of severe COVID-19. Contrary to concerns, multiple studies now suggest that ACE inhibitors and ARBs do not lead to poorer outcomes in COVID-19 infection.

"Future research should seek to [determine] how metabolic abnormalities increase viral pathogenesis, as this information will play an essential role in global preparedness against emerging seasonal and pandemic virus strains," the investigators conclude.

Metabolic Syndrome and Living Healthy - Interview With Dr. Usha Sriram at ISPEN 2019
Incidence of metabolic syndrome is high in India, with risks such as cardiovascular disease, stroke, and diabetes. There are five contributing factors and the presence of any three contributes to a diagnosis.

ASM is keeping the pulse on the SARS-CoV-2 pandemic with the COVID-19 Research Registry of top-ranked research articles curated by experts. In the eye of a pandemic, this curated database will ensure that scientists, journalists, and the public have an efficient way to find the timeliest and most valuable SARS-CoV-2/COVID-19 research from the latest journal articles and preprints.

The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.

ASM advances the microbial sciences through conferences, publications, certifications, and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry, and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

Source-Eurekalert